OptiBiotix Health (GB:OPTI) has released an update.
OptiBiotix Health plc has partnered with KAG Industries to manufacture and supply Slimbiome products in India, targeting the country’s growing middle-class population and rising obesity rates. The products, customized for the Indian market with unique flavors, will be sold under the well-known Dr Morepen brand. This strategic move leverages local manufacturing to tap into India’s significant market potential for health and wellness products.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.
